✦ LIBER ✦

PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL

✍ Scribed by J. Cristino; H. Canhão; J. Perelman; C. Santos; J. Pereira

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB

✍ A.C. Beaubrun; J.B. Daugherty 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS35 A Cost-Effectiveness Analysis of D

✍ K. Athanasakis; E. Karampli; M. Hollandezos; V. Papagiannopoulou; E. Badamgarav; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS26 Cost-Effectiveness of Denosumab Ve

✍ A. Parthan; M.M. Deflin; N. Yurgin; J. Huang; D.C. Taylor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS36 Cost-Effectiveness of Denosumab fo

✍ J. Lundkvist; M. Löthgren; E. Badamgarav; B. Freyschyss 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS48 Cost-Utility of Denosumab for the

✍ J. Darba; L. Kaskens; F. Sorio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-Utility Analysis of Tocilizumab Mon

✍ Athanasakis, K.; Konstantopoulou, T.; Tarantilis, F.; Tsalapati, K.; Vritzali, E 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB